Dave Muoio
Zebra Medical Vision receives its first 510(k) clearance for coronary artery calcification algorithm
Kibbutz Shefayim, Israel-based deep learning startup Zebra Medical Vision announced that it has received FDA 510(k) clearance for an algorithm that helps physicians quantify a patient’s coronary artery calcification.
Silicon Valley-based predictive health analytics company Lumiata has raised $11 million in a funding round led by Khosla Ventures and BlueCross BlueShield Venture Partners.
In 2016, UnitedHealthcare and Medtronic cut a deal that established the latter’s devices as the preferred insulin pumps for United members with diabetes.
A team of researchers from Tufts University, Harvard Medical School, and Purdue University, have presented academia’s latest take on the smart bandage.
San Francisco-based predictive health company Potrero Medical has closed $26.
Prying eyes.
After filing a suit in the U.
Researchers from the University of Waterloo have described a proof-of-concept system that uses Google’s Soli — an experimental, radar-based gesture tracker co-developed with Infineon — to track concentrations of glucoses within a solution.
This quarter saw a handful of digital health stories regarding payers and their new digital offerings, especially in the area of diabetes care.
New data published yesterday in the journal Hypertension offers another proof of concept for how device and mobile-driven remote monitoring can help care teams manage the conditions of a large patient population.